Drug
Hw281171
Hw281171: highest development phase Phase 1, developed by Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.
Trials
| Drug | Phase | Indication |
|---|---|---|
| HW281171 tablets NCT07936032 | Phase 1 | Chronic Urticaria |
Latest
No recent events.
Follow Hw281171 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.